ANVS
ANVS
NYSE · Biotechnology

Annovis Bio

$2.49
+0.05 (+2.05%)
As of Feb 8, 2:16 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 18.60M 19.31M 20.88M
Net Income -5,133,777 -5,587,628 -4,631,912
EPS
Profit Margin -27.6% -28.9% -22.2%
Rev Growth +22.8% -8.3% +12.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 18.30M 16.57M 18.68M
Total Equity 32.76M 33.74M 31.53M
D/E Ratio 0.56 0.49 0.59
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -5,451,350 -5,303,939 -6,015,367
Free Cash Flow -4,165,501 -4,081,500 -5,685,079